The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
出版年份 2017 全文链接
标题
The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 1, Pages 153-161
出版商
Wiley
发表日期
2017-01-18
DOI
10.1002/jcp.25804
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes
- (2016) Marika Massaro et al. PHARMACOLOGICAL RESEARCH
- The First Approved Agent in the Glitazar’s Class: Saroglitazar
- (2014) Ritesh Agrawal CURRENT DRUG TARGETS
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Fenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice
- (2011) Aki Uchida et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- Pioglitazone Compared to Glibenclamide on Lipid Profile and Inflammation Markers in Type 2 Diabetic Patients During an Oral Fat Load
- (2011) G. Derosa et al. HORMONE AND METABOLIC RESEARCH
- Effects of Thiazolidinediones and Sulfonylureas in Patients with Diabetes
- (2010) Giuseppe Derosa et al. Diabetes Technology & Therapeutics
- Efficacy and Tolerability of Pioglitazone in Patients with Type 2 Diabetes Mellitus
- (2010) Giuseppe Derosa DRUGS
- Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients
- (2010) G. Derosa et al. HORMONE AND METABOLIC RESEARCH
- ORIGINAL ARTICLE: Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin
- (2010) G. Derosa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects
- (2010) Giuseppe Derosa et al. MICROVASCULAR RESEARCH
- Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects
- (2010) Giuseppe Derosa et al. MICROVASCULAR RESEARCH
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: A role for PPAR-γ pathway
- (2009) Jasmin Khateeb et al. ATHEROSCLEROSIS
- Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment
- (2009) Giuseppe Derosa et al. BIOMEDICINE & PHARMACOTHERAPY
- Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients
- (2009) Giuseppe Derosa et al. CURRENT MEDICAL RESEARCH AND OPINION
- Oral fat load effects on inflammation and endothelial stress markers in healthy subjects
- (2009) Giuseppe Derosa et al. HEART AND VESSELS
- Oral Glucose Tolerance Test Effects on Endothelial Inflammation Markers in Healthy Subjects and Diabetic Patients
- (2009) G. Derosa et al. HORMONE AND METABOLIC RESEARCH
- Pioglitazone Metabolic Effect in Metformin-Intolerant Obese Patients Treated with Sibutramine
- (2009) Giuseppe Derosa et al. INTERNAL MEDICINE
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study
- (2009) Giuseppe Derosa et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
- (2009) Giuseppe Derosa et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
- (2009) Sho-ichi Yamagishi et al. PHARMACOLOGICAL RESEARCH
- Comparison of Effects of Simvastatin Alone Versus Fenofibrate Alone Versus Simvastatin Plus Fenofibrate on Lipoprotein Subparticle Profiles in Diabetic Patients With Mixed Dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen Study)
- (2008) Heidi T. May et al. AMERICAN JOURNAL OF CARDIOLOGY
- PPARs and the Cardiovascular System
- (2008) Milton Hamblin et al. ANTIOXIDANTS & REDOX SIGNALING
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started